Among patients with psoriasis who did not achieve Psoriasis Area and Severity Index 50 during the first course of alefacept therapy, 53% achieved Psoriasis Area and Severity Index 50 during the second course (odds rat...Among patients with psoriasis who did not achieve Psoriasis Area and Severity Index 50 during the first course of alefacept therapy, 53% achieved Psoriasis Area and Severity Index 50 during the second course (odds ratio [95% confidence interval]vs placebo 2.30 [1.26- 4.19]). Alefacept provided incremental efficacy over 5 successive 12-week treatment courses.展开更多
文摘Among patients with psoriasis who did not achieve Psoriasis Area and Severity Index 50 during the first course of alefacept therapy, 53% achieved Psoriasis Area and Severity Index 50 during the second course (odds ratio [95% confidence interval]vs placebo 2.30 [1.26- 4.19]). Alefacept provided incremental efficacy over 5 successive 12-week treatment courses.
